Results 121 to 130 of about 350,478 (232)

Access to Safety Net Programs in the U.S. During the COVID‐19 Pandemic: Barriers and Lessons From a Scoping Review

open access: yesSocial Policy &Administration, Volume 60, Issue 6, Page 1013-1035, November 2026.
ABSTRACT The COVID‐19 pandemic triggered historic expansions of the U.S. social safety net to mitigate unprecedented economic hardship. However, increased government spending and program expansions on paper do not automatically translate into equitable access in practice.
Soohyun Yoon, Jeehae Kang
wiley   +1 more source

Pneumococcal vaccination rates with 95%-confidence intervals within two years in patients with “high-risk” condition for pneumococcal disease.

open access: yes, 2019
Pneumococcal vaccination rates with 95%-confidence intervals within two years in patients with “high-risk” condition for pneumococcal disease.
Dennis Häckl (6206534)   +5 more
core   +1 more source

Will Extended‐Valency Pneumococcal Conjugate Vaccines Offer Enhanced Coverage Against Invasive Pneumococcal Disease for At‐Risk Children?

open access: yes
Acta Paediatrica, Volume 115, Issue 11, Page 2640-2643, November 2026.
Robert Cohen   +8 more
wiley   +1 more source

Pneumococcal vaccination rates with 95%-confidence intervals within three years in patients with “high-risk” condition for pneumococcal disease.

open access: yes, 2019
Pneumococcal vaccination rates with 95%-confidence intervals within three years in patients with “high-risk” condition for pneumococcal disease.
Dennis Häckl (6206534)   +5 more
core   +1 more source

Past and Present Vaccinations in Sweden

open access: yes
Acta Paediatrica, Volume 115, Issue 11, Page 2505-2510, November 2026.
Sven Arne Silfverdal
wiley   +1 more source

Cumulative pneumococcal vaccination rate within eight quarters after first documented “high-risk” condition for pneumococcal disease.

open access: yes, 2019
Cumulative pneumococcal vaccination rate within eight quarters after first documented “high-risk” condition for pneumococcal disease.
Dennis Häckl (6206534)   +5 more
core   +1 more source

Pneumococcal Infection and Vaccination-Related Knowledge, Attitudes and Practices Among Saudi Residents

open access: yesPathogens
Background and aims: Pneumococcal infections, primarily caused by Streptococcus pneumoniae, pose significant global public health challenges, particularly in vulnerable populations. In Saudi Arabia, the introduction of pneumococcal vaccination has been a
Wed S. Althobaiti   +8 more
doaj   +1 more source

Pneumococcal (Pneumonia) Vaccines [PDF]

open access: yesAmerican Journal of Respiratory and Critical Care Medicine, 2020
Phalgoon, Shah   +3 more
openaire   +2 more sources

Cumulative pneumococcal vaccination rate within twelve quarters after first documented “high-risk” condition for pneumococcal disease.

open access: yes, 2019
Cumulative pneumococcal vaccination rate within twelve quarters after first documented “high-risk” condition for pneumococcal disease.
Dennis Häckl (6206534)   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy